HIV

Delays can negatively affect treatment efficacy and the risk of morbidity and mortality among patients.

Expanded hours may be needed to overcome treatment obstacles.

Pharmacists can expect to answer patient questions related to HIV more often in the beginning of the week.

Patients should be counseled that there is no safe level of alcohol consumption.

HIV-infected men may be more sensitive to alcohol's effects.

Medication also used in treatment of Crohn's disease effective at blocking pathways.

Kick and kill strategy uses vaccine to stimulate immune system.

Specific type of lymphocyte found to impact HIV infection.

Co-administration of amiodarone with simeprevir and sofosbuvir combination is not recommended.

The American Academy of HIV Medicine has certified thousands of providers with specialist or expert designations.

Treatment dramatically reduces viral load in blood.

TAF shows signs of improved renal and bone parameters compared with Viread in clinical trials.

The FDA approved Triumeq (abacavir, dolutegravir, and lamivudine) tablets for the treatment of HIV-1 infection in patients without the HLA-B*5701 allele.

High cost of new drugs make treating even the sickest inmates impractical.

Gilead Sciences is seeking FDA approval for emtricitabine/tenofovir alafenamide.

Lack of adherence remains a major source of health care costs among HIV patients.

Accelerated aging of DNA can lead to diseases such as cancer and osteoporosis.

Vast majority of children with HIV experience recovery of immune system following therapy.

Combination fast-tracked for approval to treat chronic HCV GT1 infection in end-stage renal disease patients on hemodialysis.

While health care providers generally favor pre-exposure prophylaxis (PrEP) for patients at high risk of acquiring human immunodeficiency virus (HIV), many hesitate to actually prescribe it.

HIV antiviral therapy can prevent infection from establishing in at-risk individuals.

HIV patients need to have undetectable viral load to undergo procedure.